Thursday, 17 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14422
Articles
Company
Drug
Qilu Regor’s RGT-264 Phosphate Tablets Approved for Phase I Study
February 1, 2025
Company
Deals
Hainan Free Trade Port to Simplify Drug Import Procedures
February 1, 2025
Policy / Regulatory
Hainan Free Trade Port to Simplify Drug Import Procedures
February 1, 2025
Company
Drug
Sinovac’s Varicella Vaccine Receives WHO Pre-Qualification
February 2, 2025
Company
Drug
Reforgene Medicine RM-001 Thalassemia Gene Editing
February 1, 2025
Company
Drug
Walvax Biotech Launches Phase IIIb Trial for mRNA COVID-19 Vaccine
February 1, 2025
Company
Drug
Guangdong Zhongsheng Initiates Phase III Study for RAY1216 in COVID-19
February 1, 2025
Company
Bloomage Biotech CEO Investigated Over Discounted Share Sales
February 1, 2025
Policy / Regulatory
NMPA Proposes ‘Drug Online Sales Blacklist’ for Public Feedback
February 1, 2025
Company
Drug
Ascentage Pharma Announces Clinical Advances for Olverembatinib at ASH
February 1, 2025
Company
Drug
Abbisko Enrolls First Patient in Phase II Study for ABSK091 in Urothelial Carcinoma
February 1, 2025
Company
Drug
Blue Shield Pharma’s LD013 CAR-T Therapy Approved for Clinical Trials
February 1, 2025
1
2
…
1,102
1,103
1,104
1,105
1,106
…
1,201
1,202
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?